🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

3M, DuPont defeat massive class action over forever chemicals

Published 11/27/2023, 06:33 PM
Updated 11/28/2023, 12:28 PM
© Reuters. FILE PHOTO: The logo for DuPont de Nemours, Inc. is seen on the trading floor at the New York Stock Exchange (NYSE) in Manhattan, New York City, U.S., August 3, 2021. REUTERS/Andrew Kelly/File Photo
MMM
-
DD
-
CTVA
-

By Clark Mindock

(Reuters) -A U.S. appeals court on Monday handed 3M, Corteva (NYSE:CTVA) Inc subsidiary E.I. du Pont de Nemours and Co and other manufacturers of toxic so-called "forever chemicals" a big win in their fight against legal liability for the substances, rejecting a lower court's ruling that would have allowed about 11.8 million Ohio residents to sue the companies as a group.

The Cincinnati, Ohio-based 6th U.S. Circuit Court of Appeals vacated a lower court's approval of the massive class action, which included virtually every resident of Ohio and put considerable legal pressure on the chemical manufacturers to settle the plaintiffs' claims.

The court found lead plaintiff Kevin Hardwick filed too broad a complaint against the manufacturers, and had not shown per- and polyfluoroalkyl substances, or PFAS, found in his body could be traced directly to the defendants such as units of 3M, DuPont and others.

The court said Hardwick's complaint “rarely” targeted the actions of any one company, and instead accused the companies collectively of contaminating the environment with the chemicals.

"Seldom is so ambitious a case filed on so slight a basis," wrote Circuit Judge Raymond Kethledge, noting there are thousands of companies that have manufactured PFAS but just 10 listed as defendants in the case.

The appeals court instructed the lower court to dismiss Hardwick's lawsuit, which had aimed to force the companies to pay for studies analyzing the health impacts of PFAS. The chemicals are used in a wide range of consumer products including non-stick pans and clothing and have been tied to cancer and other diseases.

The lawsuit also sought to establish a fund to monitor Ohio residents for health impacts from PFAS exposure.

A 3M spokesperson said the company is pleased with the decision.

Robert Bilott, an attorney for Hardwick, said the court's decision runs "counter to what we know about the history of manufacturing of PFAS in the United States" and said they are evaluating whether to appeal.

Representatives for the other defendants did not immediately respond to requests for comment.

The chemicals are often referred to as forever chemicals because they do not easily break down in nature or in the human body.

The lawsuit is among thousands that have been filed against 3M, DuPont and others in recent years over alleged PFAS contamination.

© Reuters. FILE PHOTO: The logo for DuPont de Nemours, Inc. is seen on the trading floor at the New York Stock Exchange (NYSE) in Manhattan, New York City, U.S., August 3, 2021. REUTERS/Andrew Kelly/File Photo

3M agreed in June to pay $10.3 billion to settle hundreds of claims the company polluted public drinking water with the chemicals, while Chemours Co , DuPont de Nemours (NYSE:DD) Inc and Corteva reached a similar deal with U.S. water providers for $1.19 billion.

The U.S. Environmental Protection Agency has called PFAS an “urgent public health and environmental issue," and has taken steps to regulate PFAS, including in drinking water.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.